GP2 Celebrates the International Day of Women and Girls in Scienceon
This blog written by Dr. Sara Bandres-Ciga highlights women in science within the GP2 network.
The Components of GP2’s First Data Releaseon
This blog written by Hampton Leonard, Dr. Mike Nalls, Yeajin Song, and Dan Vitale describes the first data release from GP2.
Applying for GP2 Data Access on the AMP® PD Platformon
This blog written by Justin C. Solle, Claire Wegel, and Dr. Eline Appelmans outlines how to access GP2 on the AMP PD platform.
New PhD trainees increase Asian and Latin American representation in PD researchon
This blog written by Sumit Dey introduces the new PhD student trainees in the GP2 Underrepresented Populations PhD program in Asia and Latin America.
Overcoming Challenges to Black and African American Representation in Parkinson’s Researchon
This blog written by Jonathan D. Jackson, Marissa Reynolds, and Angie V. Sanchez discusses how to overcome challenges of minority representation in PD research, specifically about in regards to the BLAAC PD study
Understanding Genetic Implications of the Black and African American Connections to Parkinson’s Disease Study (BLAAC PD)on
This blog written by Dr. Sara Bandres-Ciga, Justin C. Solle, Alyssa O’Grady, and Bernadette Siddiqi describes the BLAAC PD study funded by ASAP.
Building Clinical and Genetic Data for GP2 in the Cohort Integration Working Groupon
This blog written by Dr. Huw Morris describes how the cohort integration working group within GP2 is working to harmonize clinical data.
Understanding GWAS: Part 2 – Additional Insights and Tipson
This blog written by Hampton Leonard, Dr. Mike Nalls, Yeajin Song, and Dan Vitale provides additional insights into GWAS, as a follow up to the "Understanding GWAS" blog post.
GP2 and AMP PD: Platform Partners for Progress in Parkinson’s Researchon
This blog written by Hampton Leonard, Dr. Mike Nalls, Matt Bookman, and Dr. Eline Appelmans discusses the partnership between the two initiatives.
What is Compliance and Why is it Important?on
This blog written by Tatiana Foroud, Alyssa Reimer, Claire Wegel, and Schuyler Fox outlines compliance and its importance, specifically in regards to the GP2 initiative.
This blog written by Hampton Leonard, Dr. Mike Nalls, Yeajin Song, and Dan Vitale explains GWAS.
Parkinson’s Disease Genetics: Cause, Risk, or Protection?on
This blog written by Dr. Christine Klein discusses the genetics of Parkinson's disease.
Decoding the Aliens Withinon
This blog written by Benjamin Stecher, a patient advocate and author, shows insight into his life as an individual with PD and what genetic insights can provide to understanding PD.
Open Science Opens Doorson
This blog written by Dr. Bradford Casey describes the value of open science.
A letter to the patient community from Randy Schekman, ASAP Scientific Directoron
This blog written by Dr. Randy Schekman and Benjamin Stecher describes the motivation and beginnings of the ASAP initiative. It also includes a letter written to the PD comunity by Dr. Schekman.
A Blueprint for Training and Development in GP2on
This blog written by Dr. Alastair Noyce and Dr. Sara Bandres-Ciga discusses GP2's plan to train students and investigators and the new considerations as a result of the COVID-19 pandemic.
Why study disease in different populations?on
This blog was written by Dr.Ignacio Fernandez Mata and discusses why diversity should be considered in PD research.
Increasing Underrepresented Hispanic Participation in Parkinson’s and Genomic Research Through the LARGE-PD Studyon
This blog written by Dr. Ignacio Fernandez Mata, Dr. Philippe Salles, Shilpa Rao, Miguel Inca Martinez, Nicolas Gutierrez, and Thiago Peixoto describes the LARGE-PD study and how it is increasing hispanic representation in PD research.